160 related articles for article (PubMed ID: 33014010)
1. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics screening of prognostic immune-related genes in renal clear cell carcinoma.
Cui K; Song H; Zhang H; Sun P
J Appl Genet; 2024 May; ():. PubMed ID: 38780866
[TBL] [Abstract][Full Text] [Related]
3. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
[TBL] [Abstract][Full Text] [Related]
4. Integration of bioinformatics analysis to identify possible hub genes and important pathways associated with clear cell renal cell carcinoma.
Kumar A; Yadav RP; Chatterjee S; Das M; Pal DK
Urologia; 2024 May; 91(2):261-269. PubMed ID: 38159064
[TBL] [Abstract][Full Text] [Related]
5. CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cells.
Wang K; Ding Y; Liu Y; Ma M; Wang J; Kou Z; Liu S; Jiang B; Hou S
J Cell Mol Med; 2024 Apr; 28(7):e18165. PubMed ID: 38494845
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy.
Zhong W; Li Y; Yuan Y; Zhong H; Huang C; Huang J; Lin Y; Huang J
Front Cell Dev Biol; 2021; 9():736540. PubMed ID: 34631713
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis and risk model construction for super‑enhancer‑related immune genes in clear cell renal cell carcinoma.
Bi Z; Zhou J; Ma Y; Guo Q; Ju B; Zou H; Zhan Z; Yang F; Du H; Gan X; Song E
Oncol Lett; 2024 May; 27(5):190. PubMed ID: 38495834
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of inflammation and immune-related gene NOD2 in clear cell renal cell carcinoma.
Lyu L; Min R; Zheng F; Xiang W; Huang T; Feng Y; Zhang C; Yuan J
Hum Cell; 2024 May; 37(3):782-800. PubMed ID: 38509270
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of ETS1 expression and its prognostic value in clear cell renal cell carcinoma.
Mo M; Zhu Q; Yang L; Deng Y; Yu Y; Zhou Z
Am J Transl Res; 2024; 16(4):1062-1080. PubMed ID: 38715839
[TBL] [Abstract][Full Text] [Related]
10. Highly expressed of BID indicates poor prognosis and mediates different tumor microenvironment characteristics in clear cell renal cell carcinoma.
Zeng J; Ke C; Tian K; Nie J; Huang S; Song X; Xian Z
Discov Oncol; 2024 May; 15(1):176. PubMed ID: 38767695
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of ABC transporter family member ABCG1 gene in clear cell renal cell carcinoma.
Meng F; Xiao Y; Xie L; Liu Q; Qian K
Channels (Austin); 2021 Dec; 15(1):375-385. PubMed ID: 33825659
[TBL] [Abstract][Full Text] [Related]
12. Cell Polarity Protein Pals1-Associated Tight Junction Expression Is a Favorable Prognostic Marker in Clear Cell Renal Cell Carcinoma.
Li P; Lan P; Liu S; Wang Y; Liu P
Front Genet; 2020; 11():931. PubMed ID: 33005169
[No Abstract] [Full Text] [Related]
13. Comprehensive analysis of signaling lymphocyte activation molecule family as a prognostic biomarker and correlation with immune infiltration in clear cell renal cell carcinoma.
Song N; Wang Z; Shi P; Cui K; Fan Y; Zeng L; Di W; Li J; Su W; Wang H
Oncol Lett; 2024 Aug; 28(2):354. PubMed ID: 38881710
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Transcriptomic Analysis of Critical RNA Regulation Associated With Metabolism and Prognosis in Clear Cell Renal Carcinoma.
Liu S; Zhou H; Wang G; Lian X
Front Cell Dev Biol; 2021; 9():709490. PubMed ID: 34650970
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinoma.
Wang Z; Zheng Z; Wang B; Zhan C; Yuan X; Lin X; Xin Q; Zhong Z; Qiu X
Heliyon; 2024 Apr; 10(7):e29289. PubMed ID: 38617927
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics-driven identification of prognostic biomarkers in kidney renal clear cell carcinoma.
Verma VM; Puri S; Puri V
Front Nephrol; 2024; 4():1349859. PubMed ID: 38638111
[TBL] [Abstract][Full Text] [Related]
17. Multiomics combined with single-cell analysis shows that mitophagy-related genes could accurately predict the prognosis of patients with clear cell renal cell carcinoma.
Yin H; Xiao Y; Li H; Wang Y; Zhang L; Yao A; Kang S; Cao F
Transl Cancer Res; 2024 Feb; 13(2):819-832. PubMed ID: 38482447
[TBL] [Abstract][Full Text] [Related]
18. C-type lectin 2D (CLEC2D) is upregulated in clear cell renal cell carcinoma (ccRCC) tissues and predicts poor prognosis.
Li H; Zheng P; Li Z; Han Q; Zhou B; Wang K
Heliyon; 2024 Mar; 10(6):e27354. PubMed ID: 38509909
[TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarker CPEB3 and its associations with immune infiltration in clear cell renal cell carcinoma.
Hong H; Shi X; Ou W; Ou P
Biomed Rep; 2024 Apr; 20(4):63. PubMed ID: 38476610
[TBL] [Abstract][Full Text] [Related]
20. A new prognostic model based on gamma-delta T cells for predicting the risk and aiding in the treatment of clear cell renal cell carcinoma.
Wu Y; Yao M; Wu Z; Ma L; Liu C
Discov Oncol; 2024 May; 15(1):185. PubMed ID: 38795225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
